Skip to main content

Clarification about G-CSF products

We’d like to clarify an article in the September 2018 issue of OfficeLink Updates. It refers to the use of granulocyte colony-stimulating factor (G-CSF) products.


The prior authorization requirement for G-CSF products applies to outpatient services. 


Has your patient started a course of treatment as an inpatient? Will this patient soon transition to outpatient care? If so, please note this in your precertification request. It will alert us to apply continuity-of-care policies. 


If you have questions about this policy, call 1-800-238-6279 (TTY: 711). Or visit